Join
Live feed
·
INSIDERFilingvia Quantisnow
Cogent Biosciences Inc. logo

Chief Commercial Officer Pinnow Cole bought $332,412 worth of shares (43,750 units at $7.60), increasing direct ownership by 2,085% to 45,848 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
COGT· Cogent Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COGT (Cogent Biosciences Inc.) and more on Quantisnow.